Solid Biosciences Braces for Big Drop After DMD Data

SLDB stock is heavily shorted

by Karee Venema

Published on Feb 7, 2019 at 9:19 AM

Solid Biosciences Inc (NASDAQ:SLDB) could be on track for its worst day ever, after the life sciences company reported disappointing preliminary data for its Duchenne Muscular Dystrophy (DMD) gene therapy treatment. The study includes a planned dose escalation, and the company plans to move forward with a higher dosage.

In reaction to this early data, SLDB is bracing for a 72.9% drop this morning, and is set to open at an all-time low of $6.01 per share. If these pre-market losses hold, they would surpass the stock's 64.6% plunge on March 15 as Solid Biosciences' biggest one-day drop on record. Heading into today's trading, the equity was already down 16.6% year-to-date, and closed last night at $22.34.

One group of traders is cheering today's expected plunge. Short interest on SLDB jumped 23.2% in the two most recent reporting periods to a record 2.97 million shares. These bearish bettors will likely be sidelined until early next week, with the equity all but certain to land on the short-sale restricted list out of the gate.

Analysts have yet to weigh in on SLDB stock, but a round of bear notes could be on the horizon. Currently, three of six covering brokerages maintain a "strong buy" on the security, while the average 12-month priced target sits all the way up at $43.33.

SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO
START YOUR DAY SMARTER.

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How American Lithium Tech May Be Poised for 614% Growth
A new lithium technology could change the face of lithium production forever.